アビベルチニブ 化学特性,用途語,生産方法
効能
抗悪性腫瘍薬
説明
Avitinib is a pyrrolopyrimidine-based, irreversible inhibitor of the epidermal growth factor receptor (EGFR). It is selective for EGFR-active and T790M mutations, exhibiting a 298-fold increase in potency compared with wild-type EGFR. In a xenograft model, oral administration of 500 mg/kg avitinib was shown to result in complete remission of tumors with EGFR-active and T790M mutations.
アビベルチニブ 上流と下流の製品情報
原材料
準備製品